Clinical Trial Update: A Randomized, Double-Blind, Placebo-Controlled Trial of Flumazenil for the Treatment of Obsessive Compulsive Disorder [Phase 2]

View source ↗

Summary

A Phase 2 randomized, double-blind, placebo-controlled trial evaluating flumazenil for obsessive-compulsive disorder has been terminated. No results are reporte…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Obsessive-compulsive Disorder

Drugs mentioned

• Flumazenil (flumazenil)

Snippet

Sponsor: Parkway Medical Center | Conditions: Obsessive Compulsive Disorder | Phase 2 | Status: TERMINATED